Skip to main content

Table 1 Comparison between K562 Gleevec-treated group versus K562 control group.

From: Regulation of hTERT by BCR-ABL at multiple levels in K562 cells

A. K562 Gleevec-treated group versus K562 control group

Function

Enrichment Score

Enrichment p-value

# genes in list, in group

KEGG JAK STAT SIGNALING PATHWAY

12.616000

0.000003

8

ST STAT3 PATHWAY

6.219490

0.001990

2

B. JAK-STAT Signaling Pathway

Gene Symbol

Definition

p-value (K562 Treated vs. K562 Control)

Fold-Change

(K562 Treated vs. K562 Control)

BCL2L1

Homo sapiens BCL2-like 1 (BCL2L1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA.

0.000076

-2.336810

CISH

Homo sapiens cytokine inducible SH2-containing protein (CISH), mRNA.

0.000754

-2.926860

CCND1

Homo sapiens cyclin D1 (CCND1), mRNA.

0.000964

-9.480380

SPRED1

Homo sapiens sprouty-related, EVH1 domain containing 1 (SPRED1), mRNA.

0.001425

-3.138930

SOCS1

Homo sapiens suppressor of cytokine signaling 1 (SOCS1), mRNA.

0.003518

-2.455500

IL6

Homo sapiens interleukin 6 (interferon, beta 2) (IL6), mRNA.

0.004541

-2.036640

PIK3CG

Homo sapiens phosphoinositide-3-kinase, catalytic, gamma polypeptide (PIK3CG), mRNA.

0.005740

-2.292180

PIM1

Homo sapiens pim-1 oncogene (PIM1), mRNA.

0.006760

-2.343000

  1. (a) Gene set analysis showing enrichment of gene sets under JAK/STAT pathway. These gene sets showed the number of genes that are downregulated in this pathway in K562 Gleevec-treated cells. (b) List of downregulated genes related to JAK/STAT pathway in K562 Gleevec-treated cells